Publications
56
Citations
128
Est. group size
~1
Recurring co-author estimate
Active years
12
Publishing since 2015
Yea Ji Jeong's publicly recorded work focuses on pancreatic cancer, using lab-grown 3D tissue models called organoids to study how tumor cells invade surrounding tissue. A central theme is how loss of a gene called SMAD4 (part of a cell-signaling pathway called TGF-β signaling) relates to patterns of tumor invasion and patient outcomes. This research combines cancer biology with gene-expression (transcriptomic) analysis to understand what drives pancreatic tumors to spread.
Publication output was minimal or absent for most of the decade but spiked sharply in 2023, largely due to a single major study and its associated supplementary materials, suggesting a concentrated burst of activity rather than a steady publishing pattern.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Morphology-guided transcriptomic analysis of human pancreatic cancer organoids reveals microenvironmental signals that enhance invasion
Journal of Clinical Investigation · 2023
- Supplementary Materials from Pattern of Invasion in Human Pancreatic Cancer Organoids Is Associated with Loss of SMAD4 and Clinical Outcome
2023
- Supplementary Video 3 from Pattern of Invasion in Human Pancreatic Cancer Organoids Is Associated with Loss of SMAD4 and Clinical Outcome
2023
- Supplementary Table 4 from Pattern of Invasion in Human Pancreatic Cancer Organoids Is Associated with Loss of SMAD4 and Clinical Outcome
2023
- Supplementary Figure 2 from Pattern of Invasion in Human Pancreatic Cancer Organoids Is Associated with Loss of SMAD4 and Clinical Outcome
2023
- Data from Pattern of Invasion in Human Pancreatic Cancer Organoids Is Associated with Loss of SMAD4 and Clinical Outcome
2023
- Supplementary Figure 5 from Pattern of Invasion in Human Pancreatic Cancer Organoids Is Associated with Loss of SMAD4 and Clinical Outcome
2023
- Supplementary Figure 3 from Pattern of Invasion in Human Pancreatic Cancer Organoids Is Associated with Loss of SMAD4 and Clinical Outcome
2023
- Supplementary Figure 4 from Pattern of Invasion in Human Pancreatic Cancer Organoids Is Associated with Loss of SMAD4 and Clinical Outcome
2023
- Supplementary Figure 5 from Pattern of Invasion in Human Pancreatic Cancer Organoids Is Associated with Loss of SMAD4 and Clinical Outcome
2023
- Supplementary Figure 1 from Pattern of Invasion in Human Pancreatic Cancer Organoids Is Associated with Loss of SMAD4 and Clinical Outcome
2023
- Supplementary Figure 1 from Pattern of Invasion in Human Pancreatic Cancer Organoids Is Associated with Loss of SMAD4 and Clinical Outcome
2023
- Data from Pattern of Invasion in Human Pancreatic Cancer Organoids Is Associated with Loss of SMAD4 and Clinical Outcome
2023
- Supplementary Figure 6 from Pattern of Invasion in Human Pancreatic Cancer Organoids Is Associated with Loss of SMAD4 and Clinical Outcome
2023
- Supplementary Figure 2 from Pattern of Invasion in Human Pancreatic Cancer Organoids Is Associated with Loss of SMAD4 and Clinical Outcome
2023
- Cancer Research×2
- bioRxiv (Cold Spring Harbor Laboratory)×2
- Journal of Clinical Investigation×1
- Journal of Neuropathology & Experimental Neurology×1
- Korean Journal of Veterinary Research×1
- Patrick W. Underwood
Medicine · The Ohio State University
- Subhankar Chakraborty
Medicine · The Ohio State University
- Susan Tsai
Medicine · The Ohio State University
- Margaret A. Schwarz
Medicine · Indiana University
- Susan Tsai
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile